LYPD3 Antikörper
-
- Target Alle LYPD3 Antikörper anzeigen
- LYPD3 (LY6/PLAUR Domain Containing 3 (LYPD3))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser LYPD3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human LYPD3
- Klon
- C4F10
- Isotyp
- IgG
- Top Product
- Discover our top product LYPD3 Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400
IF()
ICC 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1 mg/mL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- LYPD3 (LY6/PLAUR Domain Containing 3 (LYPD3))
- Andere Bezeichnung
- LYPD3 (LYPD3 Produkte)
- Synonyme
- LYPD3 antikoerper, MGC139913 antikoerper, C4.4A antikoerper, 2310061G07Rik antikoerper, C4.4a antikoerper, LY6/PLAUR domain containing 3 antikoerper, Ly6/Plaur domain containing 3 antikoerper, LYPD3 antikoerper, Lypd3 antikoerper
- Hintergrund
-
Synonyms: C4.4A, FLJ10525, GPI-anchored metastasis-associated protein C4.4A homolog, GPI-anchored metastasis-associated protein homolog, Ly6/PLAUR domain-containing protein 3, LYPD3_HUMAN, Matrigel-induced gene C4 protein, MIG-C4, SHINC3.
Background: Predicted to enable laminin binding activity. Predicted to act upstream of or within cell-matrix adhesion. Located in extracellular space. [provided by Alliance of Genome Resources, Nov 2021]
- Gen-ID
- 27076
- UniProt
- O95274
-